Author: The Associated Press
A leader of the Canadian government is visiting China this week for the first time in nearly a decade, a bid to rebuild his country’s fractured relations with the world’s second-largest economy — and reduce Canada’s dependence on the United States.Read More
Bunge Global shows record soybean supply, limited 2026 catalysts, a priced-in Viterra merger, and margins below historical levels. Read why BG stock is a hold.Read More
UConn’s Laurencin was the 2025 Pariser Global Lecturer at the University of North Carolina at Chapel Hill.Read More
“Exploring How Generative AI, Edge AI, and Quantum Machine Learning Are Revolutionizing Healthcare, Finance, Logistics, and Media With Real World Solutions and Expert Insights”Boston, Jan. 12, 2026 (GLOBE NEWSWIRE) — According to BCC Research’s report, “AI Use Case Analysis: Global Outlook”, emerging artificial intelligence (AI) technologies are transforming industries worldwide by driving innovation, efficiency, and new business models. This comprehensive analysis explores cutting-edge AI applRead More
As the software becomes more common, so too are questions about consumer privacy and business ethics.Read More
A lot of what we see at CES will never make it to store shelves. But every now and then, something strange, clever, or unexpected turns into the next big thing.Read More
A defense technology company is looking into purchasing the former UW-Green Bay Marinette branch campus.Read More
This is the year to sharpen business strategy, expand your network, develop your team, and innovate with purpose.Read More
Loring, which is on a former Air Force base, is Maine’s largest business park by size, with 8,700 acres, and is a key piece of Aroostook County’s place in the region’s larger economy.Read More
Exceeded 10,000 patients treated to date with CARVYKTI® (ciltacabtagene autoleucel; cilta-cel)Increased CARVYKTI® manufacturing capacity with the physical expansion of the Raritan facility, now the largest cell therapy manufacturing facility in the U.S.Profitability expected in 2026, driven by continued CARVYKTI® revenue growth and operating margin expansion Treated first patient with in vivo pipeline candidate in investigator-initiated trial Preclinical data from primates provided early validatRead More